Perinatal exposure to atazanavir-based antiretroviral regimens in a mouse model leads to differential long-term motor and cognitive deficits dependent on the NRTI backbone.

HEU HIV antiretrovirals MRI cognition hyperactivity memory neurodevelopment protease inhibitors

Journal

Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914

Informations de publication

Date de publication:
2024
Historique:
received: 26 01 2024
accepted: 19 03 2024
medline: 22 4 2024
pubmed: 22 4 2024
entrez: 22 4 2024
Statut: epublish

Résumé

Combination antiretroviral therapy (ART) use in pregnancy has been pivotal in improving maternal health and reducing perinatal HIV transmission. However, children born HIV-exposed uninfected fall behind their unexposed peers in several areas including neurodevelopment. The contribution of Dams were treated with a combination of ritonavir-boosted atazanavir with either abacavir plus lamivudine (ABC/3TC + ATV/r) or tenofovir disoproxil fumarate plus emtricitabine (TDF/FTC + ATV/r), or water as a control, administered daily from day of plug detection to birth. Offspring underwent a battery of behavioral tests that investigated motor performance and cognition starting at 6-weeks of age and ending at 8 months. Changes in brain structure were assessed using magnetic resonance imaging and immunohistochemistry. Expression of genes involved in neural circuitry and synaptic transmission were assessed in the hippocampus, a region strongly associated with memory formation, using qPCR. Pups exposed to TDF/FTC + ATV/r showed increased motor activity and exploratory drive, and deficits in hippocampal-dependent working memory and social interaction, while pups exposed to ABC/3TC + ATV/r showed increased grooming, and deficits in working memory and social interaction. Significant volumetric reductions in the brain were seen only in the ABC/3TC + ATV/r group and were associated with reduced neuronal counts in the hippocampus. Altered neurotransmitter receptor mRNA expression as well as changes in expression of the neurotrophic factor BDNF and its receptors were observed in both ART-exposed groups in a sex-dependent manner. In our model,

Sections du résumé

Background UNASSIGNED
Combination antiretroviral therapy (ART) use in pregnancy has been pivotal in improving maternal health and reducing perinatal HIV transmission. However, children born HIV-exposed uninfected fall behind their unexposed peers in several areas including neurodevelopment. The contribution of
Methods UNASSIGNED
Dams were treated with a combination of ritonavir-boosted atazanavir with either abacavir plus lamivudine (ABC/3TC + ATV/r) or tenofovir disoproxil fumarate plus emtricitabine (TDF/FTC + ATV/r), or water as a control, administered daily from day of plug detection to birth. Offspring underwent a battery of behavioral tests that investigated motor performance and cognition starting at 6-weeks of age and ending at 8 months. Changes in brain structure were assessed using magnetic resonance imaging and immunohistochemistry. Expression of genes involved in neural circuitry and synaptic transmission were assessed in the hippocampus, a region strongly associated with memory formation, using qPCR.
Findings UNASSIGNED
Pups exposed to TDF/FTC + ATV/r showed increased motor activity and exploratory drive, and deficits in hippocampal-dependent working memory and social interaction, while pups exposed to ABC/3TC + ATV/r showed increased grooming, and deficits in working memory and social interaction. Significant volumetric reductions in the brain were seen only in the ABC/3TC + ATV/r group and were associated with reduced neuronal counts in the hippocampus. Altered neurotransmitter receptor mRNA expression as well as changes in expression of the neurotrophic factor BDNF and its receptors were observed in both ART-exposed groups in a sex-dependent manner.
Interpretation UNASSIGNED
In our model,

Identifiants

pubmed: 38646101
doi: 10.3389/fnmol.2024.1376681
pmc: PMC11027900
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1376681

Informations de copyright

Copyright © 2024 Dhume, Balogun, Sarkar, Acosta, Mount, Cahill, Sled and Serghides.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Shreya H Dhume (SH)

Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.

Kayode Balogun (K)

Department of Pathology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, United States.

Ambalika Sarkar (A)

Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.

Sebastian Acosta (S)

Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.

Howard T J Mount (HTJ)

Tanz Centre for Research in Neurodegenerative Diseases, Department of Psychiatry and Physiology, University of Toronto, Toronto, ON, Canada.

Lindsay S Cahill (LS)

Department of Chemistry, Memorial University of Newfoundland, St. John's, NL, Canada.
Mouse Imaging Centre, Toronto Centre for Phenogenomics, Toronto, ON, Canada.

John G Sled (JG)

Mouse Imaging Centre, Toronto Centre for Phenogenomics, Toronto, ON, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Lena Serghides (L)

Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.
Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Women's College Research Institute, Toronto, ON, Canada.
Department of Immunology, University of Toronto, Toronto, ON, Canada.

Classifications MeSH